Sure we might attract offers, but it'd be stupidly shortsighted to sell out when we possess a cash cow like this.....Unless you thought you were gonna croak in the next few years.
Oops...thanks Kelp...I'm temporally challenged.
It seemed like 2 years so i figured it was only 1...sigh.
Gotta admit that the shorts have profitted quite nicely off our yo-yoing SP.
We all suffer our parasites.
Someone like grand turde and Short Kink who attempts to profit off the misfortune of a company trying hard to cure cancer is beneath contempt.
Right down there with ticks, mosquitos and fleas.
Given some luck, we have a long, long way to go.
Only a trader would say, "we are almost there".
and they don't count for much in the long run.
I'm pretty sure that when i was holding my little hand over my heart and learning Eisenhower's pledge of allegiance to the US in grade school;
We all said, in unison..."equal justice for all".
That aspect seems to have continuously degraded ever since.
Or perhaps i just grew up and witnessed enough of the exceptions.
All immunotherapies are vulnerable to "cytokine storms", immune over reactions.
We know they basically work, now it's a question of modulating them.
We seem to have the modulation built in to some degree.
Other competitors are developing alternate methodologies.
Thanks Larson, good post.
I wonder if their hold will last a year like ours did?
They had 3 deaths and they were presumably premature for the indication.
We had one death where the patient had long outlived her expected demise, had been in a major car wreck and suffered major surgeries with implants.
Think the FDA will be equitable?
The folks at the BPs aren't dumb and they aren't poor.
So the giant question still looms large,
Why haven't we heard from them? A lot.
Their ability to assess our constructs is doubtless superior to than of anyone here.
The inference is that we are betting on the wrong pony and if that's true..I'm really screwed!
Joseph: if you look at the history of cancer drug approval, and all the promising candidates presently stalled as people die...You'll see that you are probably over optimistic.
Chutzpa, hubris, curiosity, determination ,and calculated assessment of the evidence do not = faith.
With this outfit, the odds of failure are still significant, but the upside of success is huge. I'll take those odds at this point.
But a strong element of doubt remains.
Faith has seldom worked out all that well for me.
Is that because of how old we'll be by the time it gets approved?
I find myself trying to damp down excess enthusiasm when it swells,
and conversely pointing out the potential upside when the board is sinking.
Basically, the data is only a little more encouraging that it was when the price was 1/2 what it is now.
This is still a risky proposition with a huge potential upside...nothing more.
Clearly you haven't been around long nor are you capable of objective assessment.
Check my extensive posting history here before you embarrass yourself further.
In investing as in science, if you ignore your doubts, you are setting yourself up to get blindsided.
What i am fishing for when i express my doubts is a rational discussion of it's merits and ideally, a convincing rebuttal.
Apparently, that's too much to expect from you and Monique.
Go to the financials and look at the amounts spent on science and clinical trials VS the amounts spent on everything else, bineysr.
Of course that makes sense John:
but the bloody FDA still requires double blind studies on cancer drugs where everyone knows what the mortality rate in the placebo arm will be...Kinda stupid.
Pot is one of humanities' oldest medicinal drugs and in fact has quite a number of medical uses.
For example it is superior for quelling nausea and i wouldn't have made it through an very severe experimental chemotherapy years ago , without it.
Helpful for lower back pain as well. Many recent developments.
Amyloid deposits have been implicated in Parkinson's and i know a couple of old pot heads with that disease now.
Seems it'd be easy to prove or disprove by autopsy, as us boomers are old enough to start croaking as well as getting ALZ.
You'd like to see that in a rigorous Ph 3 study, we ain't there yet and it almost doubles the cost of the study.
Unfortunately AVXL has done a whole lot more promoting and strutting than clinical trials.
I'm, long and a sucker for a good story; but that and the lack of transparency bother me.